INJ drops 2.48% as persistent bearish momentum keeps price below key moving averages

Traders Union
All News
Crypto News
Injective slips 2.48% this week

Highlights

INJ is trading at $3.08, below its MA-20 ($3.34), MA-50 ($4.29), and MA-200 ($8.38), signaling sustained bearish pressure across all timeframes.
Momentum indicators including MACD, ADX, RSI (34.44), and Stochastic RSI all show strong sell signals, with sellers dominating and the market nearing oversold levels.
For the next five days, INJ is expected to consolidate within $2.80–$3.30; a breakdown below $2.80 could trigger further downside momentum.

Active protocol metrics and broad token allocation shape sentiment this week

Injective is a layer-1 blockchain designed for decentralized finance, and its native token supports governance, staking, and transaction fees on the network. The total supply stands at 100,000,000 tokens with a circulating supply of about 99,970,935 tokens. The current token metrics highlight ongoing protocol activity and widespread token distribution.

Downward momentum prevails as INJ breaks key weekly technical thresholds

From a weekly perspective, technicals remain firmly bearish. INJ closed below the MA-20, MA-50, and MA-200, signaling weakness across all key timeframes and underscoring strong downward momentum. Resistance is defined by the Ichimoku Kijun at $3.68, while the nearest support is found around $2.80. Weekly oscillators show consistent negative readings — MACD and ADX both remain on “Sell”, RSI is low at 34.44, and the negative CCI highlights growing oversold conditions, while the Stochastic RSI and Bear Power indicators reinforce persistent seller control.

Sideways action expected next week unless $2.80 support fails

Looking ahead over the next five to seven trading days, INJ is likely to consolidate within a normalized range of $2.80 – $3.30, with a low probability of exceeding the upper band. Baseline expectations point to sideways movement unless the $2.80 support fails, which could open the door to further declines and increased downside momentum. A decisive close above $3.68 would be needed for any short-term recovery and a push toward $3.30 – $3.50, although current momentum suggests sellers remain in control.

Anton Kharitonov, expert at Traders Union, sees persistent bearish momentum in Injective Protocol this week. The asset failed to hold above key moving averages, with price action confined to the lower end of its recent range. Technical readings, including weak oscillators and strong resistance at $3.68, confirm that negative pressure remains dominant. Kharitonov notes that oversold conditions are developing, but momentum still favors sellers. He remains cautious for the upcoming week, expecting price to consolidate near support unless $2.80 gives way. "As long as INJ stays below resistance at $3.68 and momentum is negative, I see no reason to expect a recovery in the coming week."

Last time, analysts noted that Injective remains in a sustained bearish trend, with the price trading below all major moving averages and momentum indicators such as MACD, ADX, and RSI signaling persistent oversold conditions and continued seller dominance. Immediate support is seen near $2.90, but with resistance at the Ichimoku Kijun and weak momentum, INJ is expected to consolidate sideways within a narrow range, with downside risks prevailing unless a clear bullish catalyst emerges.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.